MARKET

PPH

PPH

VanEck Vectors Pharmaceutical ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

61.52
+0.09
+0.15%
Opening 14:22 11/19 EST
OPEN
61.71
PREV CLOSE
61.43
HIGH
61.73
LOW
61.43
VOLUME
7.48K
TURNOVER
--
52 WEEK HIGH
62.90
52 WEEK LOW
52.39
TOTAL ASSET
177.61M
YTD YIELD
13.41%
1D
5D
1M
3M
1Y
5Y

Tools for In-Depth Analysis of PPH, Buy or Sell Stocks and ETFs Commission-Free!

Open a Webull account and fund it to get a free stock

PPH News

  • FDA OK'd record number of generic drugs in F19
  • Seeking Alpha - Article.10/16 16:42
  • Aprea Therapeutics upsizes IPO amid turbulent biotech market
  • Seeking Alpha - Article.10/03 14:09
  • SeaCrest Wealth Management, LLC Buys VanEck Vectors Fallen Angel High Yield ...
  • GuruFocus.com.08/03/2018 17:37
  • VanEck Vectors Pharmaceutical ETF (ASX:PPH) Gapping Lower -0.52%
  • Northfield Review (press release).08/03/2018 14:26

More

Profile

Fund Name
VanEck Vectors Pharmaceutical ETF
Risk
Medium-low risk
Inception Date
2011-12-20
Benchmark
MVIS US Listed Pharmaceutical 25 NR USD*100.0%
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Hao-Hung (Peter) Liao, George Chao, Guo Hua (Jason) Jin

Asset Allocation

176.91M
  • 99.8266%
  • 0.00%
  • 0.1734%
  • 0.00%

2019 Q2

176.91M

2019 Q1

190.29M

2018 Q4

215.77M

2018 Q3

275.74M

2018 Q2

276.39M

Dividend History

Ex-Div Date
Dividend Per Share
10/01/2019
0.2920
07/01/2019
0.2810
04/01/2019
0.3900
12/27/2018
0.2032
10/01/2018
0.2345
More